Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer Interventions: Drug: Pembrolizumab; Drug: Olaparib Sponsors: Cambridge University Hospitals NHS Foundation Trust; National Institute for Health Research, United Kingdom Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials